Latest News for: rigel
Edit
Rio Grande Sun
27 Aug 2025
Rigel to Participate in Upcoming September Investor Conferences
Rio Grande Sun
27 Aug 2025
26, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq.
Edit
Quarterly Report for Quarter Ending June 30, 2025 (Form 10-Q) (Rigel Resource Acquisition Corp)
Public Technologies 18 Aug 2025
References to the "Company," "Rigel Resource Acquisition Corp," "our," "us" or "we" refer to Rigel Resource Acquisition Corp ... Rigel Resource Acquisition Corp.
Edit
Late Filing Notice (Form NT 10-Q) (Rigel Resource Acquisition Corp)
Public Technologies 14 Aug 2025
). UNITED STATES. SECURITIES AND EXCHANGE COMMISSION. Washington, D.C. 20549. FORM 12b-25 SEC File Number. 001-41022. CUSIP Number. G7573M 106. G7573M 114 ... Rigel Resource Acquisition Corp ... N/A ... Rigel Resource Acquisition Corp ... By ... Rigel Resource Acquisition Corp.
Edit
Material Agreement, Proxy Results (Form 8-K) (Rigel Resource Acquisition Corp)
Public Technologies 13 Aug 2025
On August 13, 2025, Rigel Resource Acquisition Corp (the "Company") entered into a Promissory Note (the "Extension Loan") with its sponsor, Rigel ... Rigel Resource Acquisition Corp.
Edit
Material Agreement (Form 8-K) (Rigel Resource Acquisition Corp)
Public Technologies 08 Aug 2025
On August 4, 2025, Rigel Resource Acquisition Corp, a Cayman Islands exempted company (the "Company"), entered into a Promissory Note (the "August 2025 ... Rigel Resource Acquisition Corp.
Edit
Independent Record
06 Aug 2025
Rigel Reports Second Quarter 2025 Financial Results and Provides Business Update
Independent Record
06 Aug 2025
Edit
Initial Registration Statement for Employee Benefit Plan (Form S-8) (Rigel Pharmaceuticals Inc)
Public Technologies 06 Aug 2025
RIGEL PHARMACEUTICALS, INC ... Rigel Pharmaceuticals, Inc ... Rigel Pharmaceuticals, Inc ... Rigel Pharmaceuticals, Inc ... 333-214370) and (ii) an additional 700,000 shares of Common Stock to be issued pursuant to the Rigel Pharmaceuticals, Inc.
Edit
August 2025 (Rigel Pharmaceuticals Inc)
Public Technologies 05 Aug 2025
) Corporate Presentation. August 5, 2025. Growing Our Hematology and Oncology Business. Commercial Execution. ITP. mIDH1 R/R AML. RET Fusion-Positive. NSCLC and TC. Development & Expansion. Development Programs1 ... 1 ... FDA ... Q2 2024 ... 80 ... Rigel Pharmaceuticals Inc.
Edit
Earnings Release Q2 2025 (Rigel Pharmaceuticals Inc)
Public Technologies 05 Aug 2025
August 5, 2025 Rigel Reports Second Quarter 2025 Financial Results and Provides Business Update ... Total revenue and net income are inclusive of $40 million in non-cash contract revenue related to Rigel's agreement with Lilly ... About Rigel ... [email protected].
Edit
Earnings Presentation Q2 2025 (Rigel Pharmaceuticals Inc)
Public Technologies 05 Aug 2025
Rigel Participants ... Forma, now Novo Nordisk, is entitled to a certain portion of Rigel's sublicensing revenue from olutasidenib ... Rigel data analysis on file ... Rigel's Phase 2 Clinical Study ... Rigel anticipates 2025 total revenue of.
Edit
Quarterly Report for Quarter Ending 2025-06-30 (Form 10-Q) (Rigel Pharmaceuticals Inc)
Public Technologies 05 Aug 2025
Edit
Rio Grande Sun
30 Jul 2025
Rigel Announces Conference Call and Webcast to Report Second Quarter 2025 Financial Results and Business Update
Rio Grande Sun
30 Jul 2025
Rigel senior management will follow the .
Edit
Proxy Statement (Form DEF 14A) (Rigel Resource Acquisition Corp)
Public Technologies 28 Jul 2025- 1
- 2
- Next page »